<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1990-04-01" modified="2020-10-07" version="232">
<accession>P15923</accession>
<accession>P15883</accession>
<accession>Q14208</accession>
<accession>Q14635</accession>
<accession>Q14636</accession>
<accession>Q2TB39</accession>
<accession>Q2TB40</accession>
<accession>Q9UPI9</accession>
<name>TFE2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Transcription factor E2-alpha</fullName>
</recommendedName>
<alternativeName>
<fullName>Class B basic helix-loop-helix protein 21</fullName>
<shortName>bHLHb21</shortName>
</alternativeName>
<alternativeName>
<fullName>Immunoglobulin enhancer-binding factor E12/E47</fullName>
</alternativeName>
<alternativeName>
<fullName>Immunoglobulin transcription factor 1</fullName>
</alternativeName>
<alternativeName>
<fullName>Kappa-E2-binding factor</fullName>
</alternativeName>
<alternativeName>
<fullName>Transcription factor 3</fullName>
<shortName>TCF-3</shortName>
</alternativeName>
<alternativeName>
<fullName>Transcription factor ITF-1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">TCF3</name>
<name type="synonym">BHLHB21</name>
<name type="synonym">E2A</name>
<name type="synonym">ITF1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1990" name="Cell" volume="60" first="547" last="555">
<title>A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL.</title>
<authorList>
<person name="Kamps M.P."/>
<person name="Murre C."/>
<person name="Sun X.-H."/>
<person name="Baltimore D."/>
</authorList>
<dbReference type="PubMed" id="1967983"/>
<dbReference type="DOI" id="10.1016/0092-8674(90)90658-2"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM E12)</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH PBX1</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1990" name="Cell" volume="60" first="535" last="545">
<title>Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor.</title>
<authorList>
<person name="Nourse J."/>
<person name="Mellentin J.D."/>
<person name="Galili N."/>
<person name="Wilkinson J."/>
<person name="Stanbridge E."/>
<person name="Smith S.D."/>
<person name="Cleary M.L."/>
</authorList>
<dbReference type="PubMed" id="1967982"/>
<dbReference type="DOI" id="10.1016/0092-8674(90)90657-z"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM E12)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nature" volume="428" first="529" last="535">
<title>The DNA sequence and biology of human chromosome 19.</title>
<authorList>
<person name="Grimwood J."/>
<person name="Gordon L.A."/>
<person name="Olsen A.S."/>
<person name="Terry A."/>
<person name="Schmutz J."/>
<person name="Lamerdin J.E."/>
<person name="Hellsten U."/>
<person name="Goodstein D."/>
<person name="Couronne O."/>
<person name="Tran-Gyamfi M."/>
<person name="Aerts A."/>
<person name="Altherr M."/>
<person name="Ashworth L."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Branscomb E."/>
<person name="Caenepeel S."/>
<person name="Carrano A.V."/>
<person name="Caoile C."/>
<person name="Chan Y.M."/>
<person name="Christensen M."/>
<person name="Cleland C.A."/>
<person name="Copeland A."/>
<person name="Dalin E."/>
<person name="Dehal P."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Escobar J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Garcia C."/>
<person name="Georgescu A.M."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Ho I."/>
<person name="Huang W."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Larionov V."/>
<person name="Leem S.-H."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Lowry S."/>
<person name="Malfatti S."/>
<person name="Martinez D."/>
<person name="McCready P.M."/>
<person name="Medina C."/>
<person name="Morgan J."/>
<person name="Nelson K."/>
<person name="Nolan M."/>
<person name="Ovcharenko I."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Popkie A.P."/>
<person name="Predki P."/>
<person name="Quan G."/>
<person name="Ramirez L."/>
<person name="Rash S."/>
<person name="Retterer J."/>
<person name="Rodriguez A."/>
<person name="Rogers S."/>
<person name="Salamov A."/>
<person name="Salazar A."/>
<person name="She X."/>
<person name="Smith D."/>
<person name="Slezak T."/>
<person name="Solovyev V."/>
<person name="Thayer N."/>
<person name="Tice H."/>
<person name="Tsai M."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="Wagner M."/>
<person name="Wheeler J."/>
<person name="Wu K."/>
<person name="Xie G."/>
<person name="Yang J."/>
<person name="Dubchak I."/>
<person name="Furey T.S."/>
<person name="DeJong P."/>
<person name="Dickson M."/>
<person name="Gordon D."/>
<person name="Eichler E.E."/>
<person name="Pennacchio L.A."/>
<person name="Richardson P."/>
<person name="Stubbs L."/>
<person name="Rokhsar D.S."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
<person name="Lucas S.M."/>
</authorList>
<dbReference type="PubMed" id="15057824"/>
<dbReference type="DOI" id="10.1038/nature02399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS E47 AND 3)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1989" name="Cell" volume="56" first="777" last="783">
<title>A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins.</title>
<authorList>
<person name="Murre C."/>
<person name="McCaw P.S."/>
<person name="Baltimore D."/>
</authorList>
<dbReference type="PubMed" id="2493990"/>
<dbReference type="DOI" id="10.1016/0092-8674(89)90682-x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 214-654 (ISOFORMS E12 AND E47)</scope>
<scope>DOMAIN BHLH</scope>
<source>
<tissue>Lymphoma</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1990" name="Nucleic Acids Res." volume="18" first="677" last="677">
<title>Sequence of the cDNA encoding ITF-1, a positive-acting transcription factor.</title>
<authorList>
<person name="Henthorn P."/>
<person name="McCarrick-Walmsley R."/>
<person name="Kadesch T."/>
</authorList>
<dbReference type="PubMed" id="2308859"/>
<dbReference type="DOI" id="10.1093/nar/18.3.677"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 69-654 (ISOFORM E47)</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1991" name="DNA Seq." volume="2" first="197" last="202">
<title>Sequence of a HeLa cDNA provides the DNA binding domain and carboxy terminus of HE47: a human helix-loop-helix protein related to the enhancer binding factor E47.</title>
<authorList>
<person name="Zhang Y."/>
<person name="Bina M."/>
</authorList>
<dbReference type="PubMed" id="1818757"/>
<dbReference type="DOI" id="10.3109/10425179109039690"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 511-654 (ISOFORM E47)</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1990" name="Science" volume="247" first="467" last="470">
<title>Two distinct transcription factors that bind the immunoglobulin enhancer microE5/kappa 2 motif.</title>
<authorList>
<person name="Henthorn P."/>
<person name="Kiledjian M."/>
<person name="Kadesch T."/>
</authorList>
<dbReference type="PubMed" id="2105528"/>
<dbReference type="DOI" id="10.1126/science.2105528"/>
</citation>
<scope>DISCUSSION OF SEQUENCE</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1990" name="Proc. Natl. Acad. Sci. U.S.A." volume="87" first="4722" last="4726">
<title>Mutations that disrupt DNA binding and dimer formation in the E47 helix-loop-helix protein map to distinct domains.</title>
<authorList>
<person name="Voronova A."/>
<person name="Baltimore D."/>
</authorList>
<dbReference type="PubMed" id="2112746"/>
<dbReference type="DOI" id="10.1073/pnas.87.12.4722"/>
</citation>
<scope>MUTAGENESIS</scope>
<scope>DNA-BINDING</scope>
<scope>HOMODIMERIZATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1991" name="Blood" volume="77" first="687" last="693">
<title>The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias.</title>
<authorList>
<person name="Hunger S.P."/>
<person name="Galili N."/>
<person name="Carroll A.J."/>
<person name="Crist W.M."/>
<person name="Link M.P."/>
<person name="Cleary M.L."/>
</authorList>
<dbReference type="PubMed" id="1671560"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH PBX1</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1992" name="Science" volume="257" first="531" last="534">
<title>Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia.</title>
<authorList>
<person name="Inaba T."/>
<person name="Roberts W.M."/>
<person name="Shapiro L.H."/>
<person name="Jolly K.W."/>
<person name="Raimondi S.C."/>
<person name="Smith S.D."/>
<person name="Look A.T."/>
</authorList>
<dbReference type="PubMed" id="1386162"/>
<dbReference type="DOI" id="10.1126/science.1386162"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH HLF</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1997" name="Gene" volume="201" first="169" last="177">
<title>The mUBC9 murine ubiquitin conjugating enzyme interacts with the E2A transcription factors.</title>
<authorList>
<person name="Loveys D.A."/>
<person name="Streiff M.B."/>
<person name="Schaefer T.S."/>
<person name="Kato G.J."/>
</authorList>
<dbReference type="PubMed" id="9409784"/>
<dbReference type="DOI" id="10.1016/s0378-1119(97)00444-7"/>
</citation>
<scope>INTERACTION WITH UBE2I</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1999" name="Leukemia" volume="13" first="369" last="375">
<title>Identification of a novel molecular partner of the E2A gene in childhood leukemia.</title>
<authorList>
<person name="Brambillasca F."/>
<person name="Mosna G."/>
<person name="Colombo M."/>
<person name="Rivolta A."/>
<person name="Caslini C."/>
<person name="Minuzzo M."/>
<person name="Giudici G."/>
<person name="Mizzi L."/>
<person name="Biondi A."/>
<person name="Privitera E."/>
</authorList>
<dbReference type="PubMed" id="10086727"/>
<dbReference type="DOI" id="10.1038/sj.leu.2401338"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH TFPT</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2004" name="Mol. Endocrinol." volume="18" first="776" last="790">
<title>Orphan nuclear receptor small heterodimer partner, a novel corepressor for a basic helix-loop-helix transcription factor BETA2/neuroD.</title>
<authorList>
<person name="Kim J.Y."/>
<person name="Chu K."/>
<person name="Kim H.J."/>
<person name="Seong H.A."/>
<person name="Park K.C."/>
<person name="Sanyal S."/>
<person name="Takeda J."/>
<person name="Ha H."/>
<person name="Shong M."/>
<person name="Tsai M.J."/>
<person name="Choi H.S."/>
</authorList>
<dbReference type="PubMed" id="14752053"/>
<dbReference type="DOI" id="10.1210/me.2003-0311"/>
</citation>
<scope>INTERACTION WITH NEUROD1 AND EP300</scope>
<scope>HOMODIMERIZATION</scope>
<scope>HETERODIMERIZATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="Mol. Hum. Reprod." volume="10" first="373" last="381">
<title>Increased expression of the FIGLA transcription factor is associated with primordial follicle formation in the human fetal ovary.</title>
<authorList>
<person name="Bayne R.A.L."/>
<person name="Martins da Silva S.J."/>
<person name="Anderson R.A."/>
</authorList>
<dbReference type="PubMed" id="15044608"/>
<dbReference type="DOI" id="10.1093/molehr/gah056"/>
</citation>
<scope>INTERACTION WITH FIGLA</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-531 (ISOFORM E47)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-139 AND SER-359</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-134</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-379 AND SER-529</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2014" name="Am. J. Hum. Genet." volume="95" first="649" last="659">
<title>Mutations affecting the BHLHA9 DNA-binding domain cause MSSD, mesoaxial synostotic syndactyly with phalangeal reduction, Malik-Percin type.</title>
<authorList>
<person name="Malik S."/>
<person name="Percin F.E."/>
<person name="Bornholdt D."/>
<person name="Albrecht B."/>
<person name="Percesepe A."/>
<person name="Koch M.C."/>
<person name="Landi A."/>
<person name="Fritz B."/>
<person name="Khan R."/>
<person name="Mumtaz S."/>
<person name="Akarsu N.A."/>
<person name="Grzeschik K.H."/>
</authorList>
<dbReference type="PubMed" id="25466284"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2014.10.012"/>
</citation>
<scope>INTERACTION WITH BHLHA9</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-498</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.o114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-498</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-498 AND LYS-625</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="26">
<citation type="journal article" date="1993" name="Protein Eng." volume="6" first="41" last="50">
<title>Proposed structure for the DNA-binding domain of the helix-loop-helix family of eukaryotic gene regulatory proteins.</title>
<authorList>
<person name="Gibson T.J."/>
<person name="Thompson J.D."/>
<person name="Abagyan R.A."/>
</authorList>
<dbReference type="PubMed" id="8433970"/>
<dbReference type="DOI" id="10.1093/protein/6.1.41"/>
</citation>
<scope>3D-STRUCTURE MODELING OF 549-610</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] VAL-8</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2007" name="Genomics" volume="89" first="756" last="768">
<title>Nine-amino-acid transactivation domain: establishment and prediction utilities.</title>
<authorList>
<person name="Piskacek S."/>
<person name="Gregor M."/>
<person name="Nemethova M."/>
<person name="Grabner M."/>
<person name="Kovarik P."/>
<person name="Piskacek M."/>
</authorList>
<dbReference type="PubMed" id="17467953"/>
<dbReference type="DOI" id="10.1016/j.ygeno.2007.02.003"/>
</citation>
<scope>DOMAIN</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2013" name="J. Clin. Invest." volume="123" first="4781" last="4786">
<title>A recurrent dominant negative E47 mutation causes agammaglobulinemia and BCR(-) B cells.</title>
<authorList>
<person name="Boisson B."/>
<person name="Wang Y.D."/>
<person name="Bosompem A."/>
<person name="Ma C.S."/>
<person name="Lim A."/>
<person name="Kochetkov T."/>
<person name="Tangye S.G."/>
<person name="Casanova J.L."/>
<person name="Conley M.E."/>
</authorList>
<dbReference type="PubMed" id="24216514"/>
<dbReference type="DOI" id="10.1172/jci71927"/>
</citation>
<scope>INVOLVEMENT IN AGM8</scope>
<scope>VARIANT AGM8 LYS-555 (ISOFORM E47)</scope>
<scope>CHARACTERIZATION OF VARIANT AGM8 (ISOFORM E47) LYS-555</scope>
</reference>
<comment type="function">
<text evidence="11">Transcriptional regulator. Involved in the initiation of neuronal differentiation. Heterodimers between TCF3 and tissue-specific basic helix-loop-helix (bHLH) proteins play major roles in determining tissue-specific cell fate during embryogenesis, like muscle or early B-cell differentiation. Dimers bind DNA on E-box motifs: 5'-CANNTG-3'. Binds to the kappa-E2 site in the kappa immunoglobulin gene enhancer. Binds to IEB1 and IEB2, which are short DNA sequences in the insulin gene transcription control region.</text>
</comment>
<comment type="subunit">
<text evidence="11 16 17 24 25">Forms a heterodimer with ASH1 and TWIST2. Isoform E12 interacts with RALGAPA1 and FIGLA. Efficient DNA binding requires dimerization with another bHLH protein. Component of a nuclear TAL-1 complex composed at least of CBFA2T3, LDB1, TAL1 and TCF3. Interacts with NEUROD2, PTF1A and TGFB1I1. Forms a heterodimer with MYOG; heterodimerization enhances MYOG DNA-binding and transcriptional activities (By similarity). Homodimer. Heterodimer. Forms a heterodimer with NEUROD1; the heterodimer is inhibited in presence of ID2, but not NR0B2, to E-box element. Interacts with EP300 and UBE2I. Interacts with BHLHA9 (PubMed:25466284). Forms a heterodimer with ATOH8; repress transcription of TCF3 and TCF3/NEUROG3 dimer-induced transactivation of E box-dependent promoters (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-769630">
<id>P15923</id>
</interactant>
<interactant intactId="EBI-957042">
<id>P50553</id>
<label>ASCL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-769630">
<id>P15923</id>
</interactant>
<interactant intactId="EBI-1759806">
<id>O75593</id>
<label>FOXH1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-769630">
<id>P15923</id>
</interactant>
<interactant intactId="EBI-1387094">
<id>Q02535</id>
<label>ID3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-769630">
<id>P15923</id>
</interactant>
<interactant intactId="EBI-1753878">
<id>P17542</id>
<label>TAL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-769630">
<id>P15923</id>
</interactant>
<interactant intactId="EBI-750484">
<id>Q9Y4C2</id>
<label>TCAF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-769645">
<id>P15923-1</id>
</interactant>
<interactant intactId="EBI-748961">
<id>O95273</id>
<label>CCNDBP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-769645">
<id>P15923-1</id>
</interactant>
<interactant intactId="EBI-713450">
<id>Q02363</id>
<label>ID2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-769645">
<id>P15923-1</id>
</interactant>
<interactant intactId="EBI-488878">
<id>P15172</id>
<label>MYOD1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-769645">
<id>P15923-1</id>
</interactant>
<interactant intactId="EBI-750973">
<id>O00233</id>
<label>PSMD9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-769645">
<id>P15923-1</id>
</interactant>
<interactant intactId="EBI-1797287">
<id>Q15672</id>
<label>TWIST1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12000326">
<id>P15923-3</id>
</interactant>
<interactant intactId="EBI-12108222">
<id>Q9NQ33</id>
<label>ASCL3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12000326">
<id>P15923-3</id>
</interactant>
<interactant intactId="EBI-11320290">
<id>O96004</id>
<label>HAND1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12000326">
<id>P15923-3</id>
</interactant>
<interactant intactId="EBI-1215527">
<id>P41134</id>
<label>ID1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12000326">
<id>P15923-3</id>
</interactant>
<interactant intactId="EBI-1387094">
<id>Q02535</id>
<label>ID3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12000326">
<id>P15923-3</id>
</interactant>
<interactant intactId="EBI-11974855">
<id>Q9Y4C2-2</id>
<label>TCAF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12000326">
<id>P15923-3</id>
</interactant>
<interactant intactId="EBI-1797313">
<id>Q8WVJ9</id>
<label>TWIST2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P15923-1</id>
<name>E12</name>
<name>PAN-2</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P15923-2</id>
<name>E47</name>
<name>PAN-1</name>
<sequence type="described" ref="VSP_002155"/>
</isoform>
<isoform>
<id>P15923-3</id>
<name>3</name>
<sequence type="described" ref="VSP_057277 VSP_057278"/>
</isoform>
</comment>
<comment type="domain">
<text evidence="20 23">the 9aaTAD motif is a transactivation domain present in a large number of yeast and animal transcription factors.</text>
</comment>
<comment type="PTM">
<text evidence="10">Phosphorylated following NGF stimulation.</text>
</comment>
<comment type="disease">
<text evidence="14 15 18 21">Chromosomal aberrations involving TCF3 are cause of forms of pre-B-cell acute lymphoblastic leukemia (B-ALL). Translocation t(1;19)(q23;p13.3) with PBX1. TCF3-PBX1 transforms cells by constitutively activating transcription of genes regulated by PBX1 or by other members of the PBX protein family (PubMed:1967983, PubMed:1671560). Translocation t(17;19)(q22;p13.3) with HLF (PubMed:1386162). Inversion inv(19)(p13;q13) with TFPT (PubMed:10086727).</text>
</comment>
<comment type="disease" evidence="22">
<disease id="DI-04717">
<name>Agammaglobulinemia 8, autosomal dominant</name>
<acronym>AGM8</acronym>
<description>A form of agammaglobulinemia, a primary immunodeficiency characterized by profoundly low or absent serum antibodies and low or absent circulating B-cells due to an early block of B-cell development. Affected individuals develop severe infections in the first years of life.</description>
<dbReference type="MIM" id="616941"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform E47</molecule>
<text evidence="30">The bHLH domain encompassing amino acids 546 to 599 is sufficient to mediate DNA-binding and homodimerization. Combined mutagenesis of Phe-566 and Leu-569 to Asp-566 and Glu-569, mutagenesis of Lys-585 to Ala-585 or combined mutagenesis of Ile-588 and Leu-589 to Asp-588 and Glu-589 prevents DNA-binding and homodimerization. Mutagenesis of Arg-548 to Lys-548, combined mutagenesis of Arg-547 and Arg-548 to Gly-547 and Gly-548, mutagenesis of Arg-556 to Lys-556, mutagenesis of Arg-558 to Lys-558, or combined mutagenesis of Arg-556 and Arg-558 to Gly-556 and Gly-558, alter DNA-binding but not dimerization.</text>
</comment>
<comment type="sequence caution" evidence="30">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAA52331" version="1"/>
</conflict>
<text>Truncated N-terminus.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/E2AID50.html"/>
</comment>
<dbReference type="EMBL" id="M31523">
<property type="protein sequence ID" value="AAA61146.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M31522">
<property type="protein sequence ID" value="AAA36764.1"/>
<property type="status" value="ALT_TERM"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M31222">
<property type="protein sequence ID" value="AAA52331.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC006274">
<property type="protein sequence ID" value="AAC99797.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC005321">
<property type="protein sequence ID" value="AAC27373.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="KC877695">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC110579">
<property type="protein sequence ID" value="AAI10580.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC110580">
<property type="protein sequence ID" value="AAI10581.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M24404">
<property type="protein sequence ID" value="AAA56829.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M24405">
<property type="protein sequence ID" value="AAA56830.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X52078">
<property type="protein sequence ID" value="CAA36297.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M65214">
<property type="protein sequence ID" value="AAC41693.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS12074.1">
<molecule id="P15923-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS45899.1">
<molecule id="P15923-2"/>
</dbReference>
<dbReference type="PIR" id="A34734">
<property type="entry name" value="A34734"/>
</dbReference>
<dbReference type="PIR" id="S10099">
<property type="entry name" value="S10099"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001129611.1">
<molecule id="P15923-2"/>
<property type="nucleotide sequence ID" value="NM_001136139.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003191.1">
<molecule id="P15923-1"/>
<property type="nucleotide sequence ID" value="NM_003200.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016882669.1">
<molecule id="P15923-3"/>
<property type="nucleotide sequence ID" value="XM_017027180.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016882670.1">
<molecule id="P15923-1"/>
<property type="nucleotide sequence ID" value="XM_017027181.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016882671.1">
<property type="nucleotide sequence ID" value="XM_017027182.1"/>
</dbReference>
<dbReference type="PDB" id="1HLH">
<property type="method" value="Model"/>
<property type="chains" value="A/B=549-610"/>
</dbReference>
<dbReference type="PDB" id="2MH0">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-37"/>
</dbReference>
<dbReference type="PDB" id="2YPA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="B=546-616"/>
</dbReference>
<dbReference type="PDB" id="2YPB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.87"/>
<property type="chains" value="B=546-616"/>
</dbReference>
<dbReference type="PDB" id="3U5V">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=563-613"/>
</dbReference>
<dbReference type="PDB" id="6MGN">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=561-612"/>
</dbReference>
<dbReference type="PDBsum" id="1HLH"/>
<dbReference type="PDBsum" id="2MH0"/>
<dbReference type="PDBsum" id="2YPA"/>
<dbReference type="PDBsum" id="2YPB"/>
<dbReference type="PDBsum" id="3U5V"/>
<dbReference type="PDBsum" id="6MGN"/>
<dbReference type="BMRB" id="P15923"/>
<dbReference type="SMR" id="P15923"/>
<dbReference type="BioGRID" id="112791">
<property type="interactions" value="204"/>
</dbReference>
<dbReference type="CORUM" id="P15923"/>
<dbReference type="DIP" id="DIP-74N"/>
<dbReference type="IntAct" id="P15923">
<property type="interactions" value="42"/>
</dbReference>
<dbReference type="MINT" id="P15923"/>
<dbReference type="STRING" id="9606.ENSP00000262965"/>
<dbReference type="iPTMnet" id="P15923"/>
<dbReference type="PhosphoSitePlus" id="P15923"/>
<dbReference type="BioMuta" id="TCF3"/>
<dbReference type="DMDM" id="135655"/>
<dbReference type="EPD" id="P15923"/>
<dbReference type="jPOST" id="P15923"/>
<dbReference type="MassIVE" id="P15923"/>
<dbReference type="MaxQB" id="P15923"/>
<dbReference type="PaxDb" id="P15923"/>
<dbReference type="PeptideAtlas" id="P15923"/>
<dbReference type="PRIDE" id="P15923"/>
<dbReference type="ProteomicsDB" id="53242">
<molecule id="P15923-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="53243">
<molecule id="P15923-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="61481"/>
<dbReference type="Antibodypedia" id="4332">
<property type="antibodies" value="564 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000262965">
<molecule id="P15923-1"/>
<property type="protein sequence ID" value="ENSP00000262965"/>
<property type="gene ID" value="ENSG00000071564"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000395423">
<molecule id="P15923-3"/>
<property type="protein sequence ID" value="ENSP00000378813"/>
<property type="gene ID" value="ENSG00000071564"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000588136">
<molecule id="P15923-2"/>
<property type="protein sequence ID" value="ENSP00000468487"/>
<property type="gene ID" value="ENSG00000071564"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000611869">
<molecule id="P15923-2"/>
<property type="protein sequence ID" value="ENSP00000480564"/>
<property type="gene ID" value="ENSG00000071564"/>
</dbReference>
<dbReference type="GeneID" id="6929"/>
<dbReference type="KEGG" id="hsa:6929"/>
<dbReference type="UCSC" id="uc002ltr.3">
<molecule id="P15923-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="6929"/>
<dbReference type="DisGeNET" id="6929"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000071564.14"/>
<dbReference type="GeneCards" id="TCF3"/>
<dbReference type="HGNC" id="HGNC:11633">
<property type="gene designation" value="TCF3"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000071564">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="TCF3"/>
<dbReference type="MIM" id="147141">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="616941">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P15923"/>
<dbReference type="OpenTargets" id="ENSG00000071564"/>
<dbReference type="Orphanet" id="33110">
<property type="disease" value="Autosomal agammaglobulinemia"/>
</dbReference>
<dbReference type="Orphanet" id="99860">
<property type="disease" value="Precursor B-cell acute lymphoblastic leukemia"/>
</dbReference>
<dbReference type="PharmGKB" id="PA164742580"/>
<dbReference type="eggNOG" id="KOG3910">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000157036"/>
<dbReference type="HOGENOM" id="CLU_021099_2_1_1"/>
<dbReference type="InParanoid" id="P15923"/>
<dbReference type="KO" id="K09063"/>
<dbReference type="OMA" id="AHVHRPH"/>
<dbReference type="OrthoDB" id="571132at2759"/>
<dbReference type="PhylomeDB" id="P15923"/>
<dbReference type="TreeFam" id="TF321672"/>
<dbReference type="PathwayCommons" id="P15923"/>
<dbReference type="Reactome" id="R-HSA-525793">
<property type="pathway name" value="Myogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8939236">
<property type="pathway name" value="RUNX1 regulates transcription of genes involved in differentiation of HSCs"/>
</dbReference>
<dbReference type="SignaLink" id="P15923"/>
<dbReference type="SIGNOR" id="P15923"/>
<dbReference type="BioGRID-ORCS" id="6929">
<property type="hits" value="38 hits in 898 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="TCF3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="TCF3"/>
<dbReference type="GenomeRNAi" id="6929"/>
<dbReference type="Pharos" id="P15923">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P15923"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="RNAct" id="P15923">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000071564">
<property type="expression patterns" value="Expressed in testis and 245 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P15923">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P15923">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005719">
<property type="term" value="C:nuclear euchromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090575">
<property type="term" value="C:RNA polymerase II transcription regulator complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005667">
<property type="term" value="C:transcription regulator complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043425">
<property type="term" value="F:bHLH transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000987">
<property type="term" value="F:cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:DNA-binding transcription activator activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0001227">
<property type="term" value="F:DNA-binding transcription repressor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0070888">
<property type="term" value="F:E-box binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031435">
<property type="term" value="F:mitogen-activated protein kinase kinase kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070491">
<property type="term" value="F:repressing transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001102">
<property type="term" value="F:RNA polymerase II activating transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070644">
<property type="term" value="F:vitamin D response element binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030183">
<property type="term" value="P:B cell differentiation"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002326">
<property type="term" value="P:B cell lineage commitment"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033152">
<property type="term" value="P:immunoglobulin V(D)J recombination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0030890">
<property type="term" value="P:positive regulation of B cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045787">
<property type="term" value="P:positive regulation of cell cycle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051091">
<property type="term" value="P:positive regulation of DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051149">
<property type="term" value="P:positive regulation of muscle cell differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045666">
<property type="term" value="P:positive regulation of neuron differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000045">
<property type="term" value="P:regulation of G1/S transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902036">
<property type="term" value="P:regulation of hematopoietic stem cell differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd00083">
<property type="entry name" value="HLH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="4.10.280.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00541"/>
<dbReference type="InterPro" id="IPR011598">
<property type="entry name" value="bHLH_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036638">
<property type="entry name" value="HLH_DNA-bd_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF00010">
<property type="entry name" value="HLH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00353">
<property type="entry name" value="HLH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47459">
<property type="entry name" value="SSF47459"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50888">
<property type="entry name" value="BHLH"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0221">Differentiation</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0524">Neurogenesis</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Transcription factor E2-alpha" id="PRO_0000127466">
<location>
<begin position="1"/>
<end position="654"/>
</location>
</feature>
<feature type="domain" description="bHLH" evidence="13">
<location>
<begin position="549"/>
<end position="602"/>
</location>
</feature>
<feature type="region of interest" description="Leucine-zipper">
<location>
<begin position="389"/>
<end position="425"/>
</location>
</feature>
<feature type="short sequence motif" description="9aaTAD">
<location>
<begin position="19"/>
<end position="27"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="12">
<location>
<begin position="170"/>
<end position="176"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form TCF3-PBX1 oncogene">
<location>
<begin position="483"/>
<end position="484"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="134"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="139"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="11">
<location>
<position position="355"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="359"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="11">
<location>
<position position="371"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="379"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="529"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="7 8 9">
<location>
<position position="498"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="9">
<location>
<position position="625"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_057277" evidence="26">
<location>
<begin position="49"/>
<end position="99"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_057278" evidence="26">
<original>T</original>
<variation>TRCQPTPRHSPPSPHQDAHVHRPHAHRTHTGRPSAGPTLFPQPHCLPLAPSRRPPH</variation>
<location>
<position position="528"/>
</location>
</feature>
<feature type="splice variant" description="In isoform E47." id="VSP_002155" evidence="26 27 28 29">
<original>PDEDEDDLLPPEQKAEREKERRVANNARERLRVRDINEAFKELGRMCQLHLNSEKPQTKLLILHQAVSVILN</original>
<variation>STDEVLSLEEKDLRDRERRMANNARERVRVRDINEAFRELGRMCQMHLKSDKAQTKLLILQQAVQVILG</variation>
<location>
<begin position="530"/>
<end position="601"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal cancer sample; somatic mutation; dbSNP:rs376780559." id="VAR_036396" evidence="19">
<original>A</original>
<variation>V</variation>
<location>
<position position="8"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35354874." id="VAR_049552">
<original>L</original>
<variation>P</variation>
<location>
<position position="120"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11879402." id="VAR_049553">
<original>T</original>
<variation>A</variation>
<location>
<position position="198"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1052692." id="VAR_049554">
<original>G</original>
<variation>S</variation>
<location>
<position position="431"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; CAA36297." ref="6" evidence="30">
<original>FDPSRTFSEGTHFTESHSSLSSSTFLGPGLG</original>
<variation>GGGECLAWCGPSAVHRCADVGLGMVSARTAP</variation>
<location>
<begin position="69"/>
<end position="99"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAA56830." ref="5" evidence="30">
<original>FYV</original>
<variation>EFR</variation>
<location>
<begin position="214"/>
<end position="216"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA36764." ref="1" evidence="30">
<location>
<position position="302"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAA56830." ref="5" evidence="30">
<location>
<position position="390"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="12"/>
<end position="25"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="563"/>
<end position="580"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="588"/>
<end position="608"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="3">
<location sequence="P15923-2">
<position position="531"/>
</location>
</feature>
<feature type="sequence variant" description="In AGM8, localizes normally to the nucleus, does not perform proper DNA binding, acts in a dominant-negative manner when coexpressed with wild-type) (Ref.29." id="VAR_082832" evidence="22">
<original>E</original>
<variation>K</variation>
<location sequence="P15923-2">
<position position="555"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2MH0"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3U5V"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250"/>
<evidence key="11" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P15806"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255"/>
<evidence key="13" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00981"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10086727"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1386162"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14752053"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15044608"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1671560"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17467953"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1967983"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24216514"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2493990"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25466284"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9409784"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1818757"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2308859"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2493990"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000305"/>
<sequence length="654" mass="67600" checksum="52F5E3DE1890AE13" modified="1990-04-01" version="1">MNQPQRMAPVGTDKELSDLLDFSMMFPLPVTNGKGRPASLAGAQFGGSGLEDRPSSGSWGSGDQSSSSFDPSRTFSEGTHFTESHSSLSSSTFLGPGLGGKSGERGAYASFGRDAGVGGLTQAGFLSGELALNSPGPLSPSGMKGTSQYYPSYSGSSRRRAADGSLDTQPKKVRKVPPGLPSSVYPPSSGEDYGRDATAYPSAKTPSSTYPAPFYVADGSLHPSAELWSPPGQAGFGPMLGGGSSPLPLPPGSGPVGSSGSSSTFGGLHQHERMGYQLHGAEVNGGLPSASSFSSAPGATYGGVSSHTPPVSGADSLLGSRGTTAGSSGDALGKALASIYSPDHSSNNFSSSPSTPVGSPQGLAGTSQWPRAGAPGALSPSYDGGLHGLQSKIEDHLDEAIHVLRSHAVGTAGDMHTLLPGHGALASGFTGPMSLGGRHAGLVGGSHPEDGLAGSTSLMHNHAALPSQPGTLPDLSRPPDSYSGLGRAGATAAASEIKREEKEDEENTSAADHSEEEKKELKAPRARTSPDEDEDDLLPPEQKAEREKERRVANNARERLRVRDINEAFKELGRMCQLHLNSEKPQTKLLILHQAVSVILNLEQQVRERNLNPKAACLKRREEEKVSGVVGDPQMVLSAPHPGLSEAHNPAGHM</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

